View in EDS HTML Full Text PDF Full Text

Incorporation of SKI-G-801, a Novel AXL Inhibitor, With Anti-PD-1 Plus Chemotherapy Improves Anti-Tumor Activity and Survival by Enhancing T Cell Immunity.

Saved in:
Bibliographic Details
Title: Incorporation of SKI-G-801, a Novel AXL Inhibitor, With Anti-PD-1 Plus Chemotherapy Improves Anti-Tumor Activity and Survival by Enhancing T Cell Immunity.
Authors: Lee W; JEUK Institute for Cancer Research, JEUK Co., Ltd., Gumi-si, South Korea.; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Kim DK; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Synn CB; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Lee HK; Department of Discovery Biology, Oscotec Inc., Seongnam, South Korea., Park S; Department of Discovery Biology, Oscotec Inc., Seongnam, South Korea., Jung DS; Department of Discovery Biology, Oscotec Inc., Seongnam, South Korea., Choi Y; Department of Discovery Biology, Oscotec Inc., Seongnam, South Korea., Kim JH; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Byeon Y; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Kim YS; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Lee S; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Lee S; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Joo Y; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Lee EJ; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Yun MR; JEUK Institute for Cancer Research, JEUK Co., Ltd., Gumi-si, South Korea., Heo SG; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Yang W; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Jung JE; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Kim EK; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Park J; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Park JD; Wide River Institute of Immunology, Seoul National University, Hongcheon, South Korea.; Department of Pediatrics, Seoul National University College of Medicine, Seoul, South Korea., Lee DJ; Wide River Institute of Immunology, Seoul National University, Hongcheon, South Korea., Kim HW; Wide River Institute of Immunology, Seoul National University, Hongcheon, South Korea., Lim SM; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea., Hong MH; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea., Ahn BC; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.; Center for Lung Cancer, National Cancer Center, Goyang-si, South Korea., Lee JB; Division of Hemato-oncology, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, Wonju, South Korea., Pyo KH; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.
Source: Frontiers in oncology [Front Oncol] 2022 Mar 09; Vol. 12, pp. 821391. Date of Electronic Publication: 2022 Mar 09 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35356198
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Incorporation of SKI-G-801, a Novel AXL Inhibitor, With Anti-PD-1 Plus Chemotherapy Improves Anti-Tumor Activity and Survival by Enhancing T Cell Immunity.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lee+W%22">Lee W</searchLink>; JEUK Institute for Cancer Research, JEUK Co., Ltd., Gumi-si, South Korea.; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Kim+DK%22">Kim DK</searchLink>; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Synn+CB%22">Synn CB</searchLink>; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Lee+HK%22">Lee HK</searchLink>; Department of Discovery Biology, Oscotec Inc., Seongnam, South Korea.<br /><searchLink fieldCode="AU" term="%22Park+S%22">Park S</searchLink>; Department of Discovery Biology, Oscotec Inc., Seongnam, South Korea.<br /><searchLink fieldCode="AU" term="%22Jung+DS%22">Jung DS</searchLink>; Department of Discovery Biology, Oscotec Inc., Seongnam, South Korea.<br /><searchLink fieldCode="AU" term="%22Choi+Y%22">Choi Y</searchLink>; Department of Discovery Biology, Oscotec Inc., Seongnam, South Korea.<br /><searchLink fieldCode="AU" term="%22Kim+JH%22">Kim JH</searchLink>; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Byeon+Y%22">Byeon Y</searchLink>; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Kim+YS%22">Kim YS</searchLink>; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Lee+S%22">Lee S</searchLink>; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Lee+S%22">Lee S</searchLink>; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Joo+Y%22">Joo Y</searchLink>; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Lee+EJ%22">Lee EJ</searchLink>; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Yun+MR%22">Yun MR</searchLink>; JEUK Institute for Cancer Research, JEUK Co., Ltd., Gumi-si, South Korea.<br /><searchLink fieldCode="AU" term="%22Heo+SG%22">Heo SG</searchLink>; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Yang+W%22">Yang W</searchLink>; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Jung+JE%22">Jung JE</searchLink>; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Kim+EK%22">Kim EK</searchLink>; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Park+J%22">Park J</searchLink>; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Park+JD%22">Park JD</searchLink>; Wide River Institute of Immunology, Seoul National University, Hongcheon, South Korea.; Department of Pediatrics, Seoul National University College of Medicine, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Lee+DJ%22">Lee DJ</searchLink>; Wide River Institute of Immunology, Seoul National University, Hongcheon, South Korea.<br /><searchLink fieldCode="AU" term="%22Kim+HW%22">Kim HW</searchLink>; Wide River Institute of Immunology, Seoul National University, Hongcheon, South Korea.<br /><searchLink fieldCode="AU" term="%22Lim+SM%22">Lim SM</searchLink>; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Hong+MH%22">Hong MH</searchLink>; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Ahn+BC%22">Ahn BC</searchLink>; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.; Center for Lung Cancer, National Cancer Center, Goyang-si, South Korea.<br /><searchLink fieldCode="AU" term="%22Lee+JB%22">Lee JB</searchLink>; Division of Hemato-oncology, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, Wonju, South Korea.<br /><searchLink fieldCode="AU" term="%22Pyo+KH%22">Pyo KH</searchLink>; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2022 Mar 09; Vol. 12, pp. 821391. <i>Date of Electronic Publication: </i>2022 Mar 09 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35356198
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fonc.2022.821391
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 821391
    Titles:
      – TitleFull: Incorporation of SKI-G-801, a Novel AXL Inhibitor, With Anti-PD-1 Plus Chemotherapy Improves Anti-Tumor Activity and Survival by Enhancing T Cell Immunity.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lee W
      – PersonEntity:
          Name:
            NameFull: Kim DK
      – PersonEntity:
          Name:
            NameFull: Synn CB
      – PersonEntity:
          Name:
            NameFull: Lee HK
      – PersonEntity:
          Name:
            NameFull: Park S
      – PersonEntity:
          Name:
            NameFull: Jung DS
      – PersonEntity:
          Name:
            NameFull: Choi Y
      – PersonEntity:
          Name:
            NameFull: Kim JH
      – PersonEntity:
          Name:
            NameFull: Byeon Y
      – PersonEntity:
          Name:
            NameFull: Kim YS
      – PersonEntity:
          Name:
            NameFull: Lee S
      – PersonEntity:
          Name:
            NameFull: Lee S
      – PersonEntity:
          Name:
            NameFull: Joo Y
      – PersonEntity:
          Name:
            NameFull: Lee EJ
      – PersonEntity:
          Name:
            NameFull: Yun MR
      – PersonEntity:
          Name:
            NameFull: Heo SG
      – PersonEntity:
          Name:
            NameFull: Yang W
      – PersonEntity:
          Name:
            NameFull: Jung JE
      – PersonEntity:
          Name:
            NameFull: Kim EK
      – PersonEntity:
          Name:
            NameFull: Park J
      – PersonEntity:
          Name:
            NameFull: Park JD
      – PersonEntity:
          Name:
            NameFull: Lee DJ
      – PersonEntity:
          Name:
            NameFull: Kim HW
      – PersonEntity:
          Name:
            NameFull: Lim SM
      – PersonEntity:
          Name:
            NameFull: Hong MH
      – PersonEntity:
          Name:
            NameFull: Ahn BC
      – PersonEntity:
          Name:
            NameFull: Lee JB
      – PersonEntity:
          Name:
            NameFull: Pyo KH
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 09
              M: 03
              Text: 2022 Mar 09
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 2234-943X
          Numbering:
            – Type: volume
              Value: 12
          Titles:
            – TitleFull: Frontiers in oncology
              Type: main
ResultId 1